Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹3,955 Cr
Revenue (TTM)
₹2,712 Cr
Net Profit (TTM)
₹3 Cr
ROE
-2.7 %
ROCE
-0 %
P/E Ratio
--
P/B Ratio
0.7
Industry P/E
101.25
EV/EBITDA
11.3
Div. Yield
0 %
Debt to Equity
0.2
Book Value
₹371.9
EPS
₹1.8
Face value
2
Shares outstanding
156,783,095
CFO
₹2,914.95 Cr
EBITDA
₹3,138.49 Cr
Net Profit
₹338.86 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dishman Carbogen
| -6.8 | 18.6 | 14.1 | 31.2 | 27.8 | 27.9 | -- |
|
BSE Healthcare
| -5.9 | 0.5 | 7.3 | 18.6 | 22.8 | 22.3 | 9.5 |
|
BSE Small Cap
| -6.0 | 4.8 | 12.4 | 7.4 | 25.0 | 37.4 | 16.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Dishman Carbogen
| 51.1 | 80.1 | -52.9 | 41.8 | 76.7 | -63.8 | -28.1 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dishman Carbogen
|
252.1 | 3,954.9 | 2,711.5 | 3.2 | 6.5 | 0.5 | -- | 0.7 |
| 25.2 | 109.0 | 44.6 | -16.6 | -- | 0 | -- | -- | |
| 52.1 | 15.9 | 0.6 | 0.4 | 65.5 | 10.5 | 41.1 | 4.0 | |
| 116.9 | 416.9 | 132.8 | 3.8 | 5.7 | 4.9 | 101.3 | 4.1 | |
| 246.7 | 11,181.8 | 2,622.8 | 382.6 | 17.0 | 16 | 29.4 | 4.5 | |
| 30.7 | 923.7 | 1,006.4 | 46.5 | 8.0 | 11 | 19.9 | 2.1 | |
| 5,009.8 | 11,544.1 | 667.6 | 168.3 | 37.0 | 82.8 | 68.6 | 35.8 | |
| 9.6 | 144.7 | 13.2 | -68.3 | -175.4 | -- | -- | -17.5 | |
| 38.0 | 68.1 | 46.7 | 7.3 | 24.6 | 10.6 | 9.4 | 0.9 |
No Review & Analysis are available.
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules... segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP. Read more
Incorporated
2007
Chairman
Janmejay R Vyas
Managing Director
Arpit J Vyas
Group
Dishman Pharma
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Dishman Carbogen Amcis Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Dishman Carbogen Amcis Ltd stood at ₹ 9,999 Cr as on 31-Mar-25
The share price of Dishman Carbogen Amcis Ltd is ₹252.07 (NSE) and ₹252.25 (BSE) as of 23-May-2025 IST. Dishman Carbogen Amcis Ltd has given a return of 27.75% in the last 3 years.
Dishman Carbogen Amcis Ltd has a market capitalisation of ₹ 3,955 Cr as on 23-May-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Dishman Carbogen Amcis Ltd is 0.68 times as on 23-May-2025, a 27% discount to its peers’ median range of 0.93 times.
Since, TTM earnings of Dishman Carbogen Amcis Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Dishman Carbogen Amcis Ltd and enter the required number of quantities and click on buy to purchase the shares of Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
The promoter of Dishman Carbogen Amcis Ltd is Adimans Technologies LLP. Adimans Technologies LLP owns 59.32 per cent of the total equity. The chairman of the company is Janmejay R Vyas , and the managing director is Arpit J Vyas..
There is no promoter pledging in Dishman Carbogen Amcis Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
417
|
|
|
145
|
|
|
109
|
|
|
68
|
|
|
16
|
|
|
11,544
|
|
|
11,182
|
|
|
924
|
|
|
417
|
| Dishman Carbogen Amcis Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
0.5
|
|
Operating margin(%)
|
6.46
|
|
Net Margin(%)
|
0.12
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Dishman Carbogen Amcis Ltd was ₹3 Cr.
₹6.83
(
